Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL ...Middle East

PR Newswire - News
SHANGHAI and HONG KONG, Jan. 3, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology...

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL )

Apple Storegoogle play

Also on site :